AstraZeneca Pharma India Dividends and Buybacks
Dividend criteria checks 2/6
AstraZeneca Pharma India is a dividend paying company with a current yield of 0.38% that is well covered by earnings.
Key information
0.4%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | 32.2% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₹24.000 |
| Payout ratio | 37% |
Recent dividend and buyback updates
Recent updates
AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) Earnings Haven't Escaped The Attention Of Investors
Sep 18
We Believe AstraZeneca Pharma India's (NSE:ASTRAZEN) Earnings Are A Poor Guide For Its Profitability
Jun 03Why Investors Shouldn't Be Surprised By AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) P/S
May 22We Ran A Stock Scan For Earnings Growth And AstraZeneca Pharma India (NSE:ASTRAZEN) Passed With Ease
Apr 04Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?
Nov 10AstraZeneca Pharma India's (NSE:ASTRAZEN) Dividend Will Be Increased To ₹16.00
Jul 06Is Now The Time To Put AstraZeneca Pharma India (NSE:ASTRAZEN) On Your Watchlist?
Jun 16Increases to CEO Compensation Might Be Put On Hold For Now at AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
Aug 02Here's Why I Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is An Interesting Stock
Feb 25Could The AstraZeneca Pharma India Limited (NSE:ASTRAZEN) Ownership Structure Tell Us Something Useful?
Feb 04Declining Stock and Solid Fundamentals: Is The Market Wrong About AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?
Jan 18
Announcing: AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Increased An Energizing 282% In The Last Five Years
Dec 31We're Not Counting On AstraZeneca Pharma India (NSE:ASTRAZEN) To Sustain Its Statutory Profitability
Dec 13Here's Why We Think AstraZeneca Pharma India (NSE:ASTRAZEN) Is Well Worth Watching
Nov 25Here's What We Think About AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Pay
Nov 07What Kind Of Investors Own Most Of AstraZeneca Pharma India Limited (NSE:ASTRAZEN)?
Oct 20AstraZeneca Pharma India Limited's (NSE:ASTRAZEN) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Sep 24If You Had Bought AstraZeneca Pharma India (NSE:ASTRAZEN) Stock Three Years Ago, You Could Pocket A 298% Gain Today
Aug 28What Did AstraZeneca Pharma India's (NSE:ASTRAZEN) CEO Take Home Last Year?
Aug 02Stability and Growth of Payments
Fetching dividends data
Stable Dividend: ASTRAZEN has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: ASTRAZEN's dividend payments have increased, but the company has only paid a dividend for 5 years.
Dividend Yield vs Market
| AstraZeneca Pharma India Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ASTRAZEN) | 0.4% |
| Market Bottom 25% (IN) | 0.3% |
| Market Top 25% (IN) | 1.2% |
| Industry Average (Pharmaceuticals) | 0.7% |
| Analyst forecast (ASTRAZEN) (up to 3 years) | n/a |
Notable Dividend: ASTRAZEN's dividend (0.38%) is higher than the bottom 25% of dividend payers in the Indian market (0.25%).
High Dividend: ASTRAZEN's dividend (0.38%) is low compared to the top 25% of dividend payers in the Indian market (1.15%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (37.1%), ASTRAZEN's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (721.2%), ASTRAZEN's dividend payments are not well covered by cash flows.